Clinical Trials on Delayed Type Hypersensitivity in Australia
Total 4063 results
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
Astellas Pharma IncCompletedAtopic DermatitisAustralia, Belgium, Poland, Hungary, Portugal, Germany, Iceland, Malta
-
Medical University of ViennaCompleted
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Garvan Institute of Medical ResearchCompleted
-
Chiesi Farmaceutici S.p.A.CompletedAsthmaSpain, Austria, Italy, Poland
-
Bristol-Myers SquibbCompletedDiabetes Type 2United States, Canada, Korea, Republic of, Australia
-
Boston Scientific CorporationCompletedAsthmaUnited States, United Kingdom, Australia, Brazil, Canada, Denmark, Netherlands
-
Provectus Biopharmaceuticals, Inc.Active, not recruitingNeuroendocrine Tumors Metastatic to the LiverAustralia
-
John Hunter HospitalCompletedType 1 Diabetes MellitusAustralia
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
Medical University of ViennaNational Bank of AustriaUnknownInsulin Resistance | Diabetes Mellitus Type 2Austria
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Korea, Republic of, Poland, Italy, Germany, Argentina, Austria, Japan, Taiwan
-
GlaxoSmithKlineCompletedAsthmaCanada, Bulgaria, Estonia, Spain, Netherlands, Germany, Australia, Austria, Belgium, Finland, Ireland, Latvia, Macedonia, The Former Yugoslav Republic of, New Zealand, United Kingdom
-
Medical University of ViennaUnknownType 2 Diabetes | Metabolically Healthy ControlsAustria
-
MetaCure LimitedCompleted
-
Eli Lilly and CompanyIncyte CorporationCompletedAtopic DermatitisSpain, Australia, Switzerland, Israel, Korea, Republic of, Japan, Poland, Argentina, Austria, Hungary
-
NGM Biopharmaceuticals, IncCompleted
-
German Diabetes CenterCompleted
-
Technische Universität DresdenCompleted
-
Medical University of GrazCompleted
-
Medical University of ViennaUnknownType 2 Diabetes Mellitus | Endothelial Dysfunction | Cardiovascular RiskAustria
-
GlaxoSmithKlineCompletedAsthmaUnited States, Australia, Germany, Russian Federation, Bulgaria, Canada, Chile, Peru, Philippines, South Africa, Thailand, Mexico, Israel, Ukraine, New Zealand, Croatia
-
Boehringer IngelheimPfizerCompletedAsthmaAustria, Czech Republic, Estonia, Germany, Latvia
-
DBV TechnologiesRecruitingAllergy, PeanutUnited States, Canada, France, Germany, Ireland, Netherlands, Spain, United Kingdom, Australia
-
Novartis PharmaceuticalsTerminatedCarcinoma, Renal CellAustralia, Korea, Republic of
-
Ascensia Diabetes CareCompleted
-
Medical University of GrazMenarini GroupCompleted
-
Panbela Therapeutics, Inc.CompletedPancreatic Cancer | Ductal Adenocarcinoma of the PancreasUnited States, Australia
-
The Queen Elizabeth HospitalCompleted
-
Medical University of ViennaCompleted
-
Medical University of ViennaCompletedType I DiabetesAustria
-
The Queen Elizabeth HospitalUniversity of AdelaideCompletedTobacco DependenceAustralia
-
Landeskrankenhaus FeldkirchCompleted
-
Alexandra Kautzky-WillerBayerRecruitingFatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes MellitusAustria
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, France, Germany, Poland, Romania, Russian Federation, Canada, Chile, Korea, Republic of, Ukraine, United Kingdom
-
Medical University of GrazCompleted
-
Medical University of GrazMedical University of ViennaCompletedType 1 DiabetesAustria
-
Medical University of GrazMenarini GroupCompleted
-
Landsteiner InstitutUniversity of CoimbraCompletedType 1 Diabetes MellitusAustria
-
University of AdelaideUniversity of Sydney; Salk Institute for Biological StudiesRecruiting
-
AllerganCompletedAtopic ConjunctivitisCanada, Czech Republic, United States, Italy, Israel, New Zealand, Spain, India, Germany, Australia, France, United Kingdom
-
Medical University of GrazEuropean CommissionCompleted
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
PfizerCompletedPlaque-type PsoriasisAustralia
-
Medical University of GrazCompleted
-
Medical University of GrazNovo Nordisk A/SCompletedType 1 Diabetes MellitusAustria
-
DiObexTerminatedType 2 DiabetesAustralia, United States, New Zealand
-
Dizal PharmaceuticalsNot yet recruitingLymphoma, Non-HodgkinAustralia